Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49.9M
-
Number of holders
-
90
-
Total 13F shares, excl. options
-
38.8M
-
Shares change
-
+1.57M
-
Total reported value, excl. options
-
$560M
-
Value change
-
+$17.2M
-
Number of buys
-
63
-
Number of sells
-
-24
-
Price
-
$14.46
Significant Holders of HilleVax, Inc. - Common Stock (HLVX) as of Q2 2024
103 filings reported holding HLVX - HilleVax, Inc. - Common Stock as of Q2 2024.
HilleVax, Inc. - Common Stock (HLVX) has 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.8M shares
of 49.9M outstanding shares and own 77.75% of the company stock.
Largest 10 shareholders include Frazier Life Sciences Management, L.P. (10.6M shares), TAKEDA PHARMACEUTICAL CO LTD (6.72M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (4M shares), T. Rowe Price Investment Management, Inc. (3.48M shares), BlackRock Inc. (2.09M shares), FRANKLIN RESOURCES INC (1.99M shares), Carlyle Group Inc. (1.84M shares), Deep Track Capital, LP (1.83M shares), VANGUARD GROUP INC (1.4M shares), and Catalys Pacific, LLC (1.21M shares).
This table shows the top 90 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.